OBCN update on Doki mess provided by AI Grok
FTRS and OBCN in the Doki/Vivos Mess: Parallel Shell Games and Ongoing RisksYour question ties directly into the broader "Doki mess"—the web of aggressive reverse mergers, undisclosed debts, and fraud allegations that sank the Vivos Group (Naveen Doki's staffing/IT roll-up empire) and left RLBY (Reliability Incorporated, OTC: RLBY) in a multi-year receivership battle. Based on a deep dive into SEC filings, court records, and investor forums (primarily InvestorsHub, where this saga plays out like a micro-cap soap opera), FTRS (Futuris Company, OTC Pink: FTRS) and OBCN (Obocon Inc., OTC Expert Market: OBCN) are adjacent shells heavily influenced or controlled by Doki and his network. They represent the "next chapter" of Doki's playbook: Using dormant public companies for staffing/tech mergers, much like the 2019 RLBY reverse merger that triggered the $8.65M judgment against Vivos/Doki (as of Q3 2025).Neither FTRS nor OBCN is directly named in RLBY's Vivos litigation (which focuses on 2019-2023 defaults and asset dissipation), but they embody the hostile, value-destructive patterns—delayed audits, dilution via share dumps, and stalled operations—that have defined Doki's involvement in OTC shells. Investor sentiment labels them "Doki trash" extensions, with fears of repeated fraud claims. Below, I break it down by ticker, with ties to the RLBY saga, current status (as of November 15, 2025), and implications.1. FTRS (Futuris Company): Doki's "Plan B" for Vivos ExpansionFTRS is the most explicitly linked to Doki's pre-RLBY ambitions and post-merger pivots. It's a Wyoming-incorporated shell (traded since ~2020) that Doki and affiliates (e.g., brother Suresh Doki, Kalyan Pathuri) attempted to repurpose for healthcare staffing roll-ups—mirroring the Vivos strategy that imploded at RLBY.Role in the Doki Mess:Origin Story: In 2019, Doki planned an IPO for Vivos Holdings (his core entity) but pivoted to reverse mergers after it failed. He successfully merged Maslow Media Group (MMG, $32M revenue staffing firm) into RLBY (Oct 29, 2019), gaining ~84% control via ~10M shares (now frozen/seizable by RLBY's receiver).
investorshub.advfn.com
Maslow directors then blocked further Doki-led deals (e.g., Nov 2019 acquisition of Intelligent Quality Solutions from Vivos), exposing ~$7M in undisclosed notes—sparking the arbitration losses.
FTRS as Fallback: With RLBY turning hostile, Doki shifted to FTRS. In 2021, FTRS announced acquisitions like Health HR Inc. (medical staffing) and appointed Suresh Doki to the board (with 30+ years in staffing, per press releases).
stocktitan.net
Pathuri (husband of Vivos affiliate Silvija Valleru) became president, signing a 3-year deal. This was pitched as building "integrated HCM [human capital management] capabilities" via revenue-accretive partnerships—echoing Vivos' failed roll-up.
Ties to Vivos/RLBY Drama: Forum posts allege Doki used FTRS to "launder" Vivos assets or fund RLBY legal fights, with share sales covering "legal bills" from the arbitration.
investorshub.advfn.com
RLBY's filings reference Vivos' 2019 share swaps involving Doki family trusts (e.g., Igly Trust, Judos Trust), which may overlap with FTRS control.
q10k.com
No direct clawbacks yet, but RLBY's receiver could probe if fraudulent transfers are traced here.
Current Status (Nov 2025):Metric
Details
Notes
Share Price
~$0.0087-$0.0179 (volatile, +15% in last 24h)
Ultra-low liquidity; down 99%+ from 2021 peaks.
Market Cap
<$1M
~100M+ shares outstanding; heavy dilution risks.
Operations
Dormant; last PR Jan 2024 (4-year OTC anniversary)
No revenue reported; audits stalled since 2021.
Ownership
Doki/Pathuri affiliates dominant
Suresh Doki resigned post-2021; CFO Eric Stutzke left unannounced ~2023.
Regulatory
Pink Current (OTC-ID accepted May 2025)
But "expert market" whispers on forums; no 10-Ks filed recently.
Investor View: InvestorsHub calls it "Doki weed" and a "criminal copycat" of legit uplists (e.g., AMRH), predicting "triple zeros" without RLBY resolution.
investorshub.advfn.com
Recent volume spikes tied to RLBY's Oct 2025 hearing—bets on spillover.
Risks/Outlook: FTRS is stalled by the same "Doki hostility" plaguing RLBY (e.g., appeals delaying collections). If RLBY seizes Doki's frozen shares (~10% of RLBY float), it could pressure FTRS liquidity. Upside: Clean merger post-resolution (low probability). Downside: Further dilution or custodianship.
2. OBCN (Obocon Inc.): The "Empty Shell" with Super-Powered Doki ControlOBCN is a deeper-cut casualty—an inactive chemical/tech shell (pre-2010s vintage) that Doki reportedly hijacked via preferred shares, turning it into another dormant vehicle. It's less active than FTRS but exemplifies Doki's pattern of grabbing control without execution.Role in the Doki Mess:Acquisition & Control: Around 2020-2022 (post-RLBY merger), Doki affiliates (possibly via Vivos entities) took over OBCN, granting Naveen Doki "super powers" through preferred shares (e.g., voting overrides, dilution rights).
investorshub.advfn.com
This mirrors RLBY's 84% grab but without a meaningful merger—leaving it as an "empty shell" for potential staffing pivots.
Ties to Vivos/RLBY Drama: Direct forum links: "FTRS and OBCN IMO will never do anything with Doki trash fraudsters involved... Over at RLBY Doki trash got involved and took 3 years to get rid of them."
investorshub.advfn.com
Other owners (e.g., DB Capital/Daniel Sobolewski with ~13M post-split shares; Jeffrey Beckett ~3.6M) have distanced themselves, citing unhappiness with Doki's crew (e.g., "Wolfson’s" drama—likely a promoter reference). No explicit Vivos asset transfers, but the timing aligns with RLBY's 2020-2022 defaults, when Doki sought new shells amid liquidity crunches.
Broader Pattern: Like Vivos' 2017-2019 factoring defaults ($1.09M NJ judgment), OBCN's inactivity stems from unfulfilled promises—e.g., no audits, no ops revival.
fintel.io
Investors speculate it was a "tax write-off" play, with Doki using it to park inter-company loans.
Current Status (Nov 2025):Metric
Details
Notes
Share Price
~$0.000001 (down 99% in last 24h)
Essentially worthless; no trades in months.
Market Cap
Near-zero
100B+ shares post-splits; extreme dilution.
Operations
None; "empty shell" since takeover
No filings since ~2022; chemical legacy irrelevant.
Ownership
Doki dominant (preferred shares); Sobolewski/Beckett minorities
Doki's stake undisclosed but "no info on shares."
investorshub.advfn.com
Regulatory
Expert Market (restricted quotes)
High fraud risk tier; custodianship calls on forums.
Investor View: Pure despair—"CLSI / OBCN is a tax write off... Worthless stock... Bollywood curry criminals."
investorshub.advfn.com
2022 posts lament total investment loss, with pleas for custodianship (court takeover).
investorshub.advfn.com
Risks/Outlook: OBCN is the "deader" end of the Doki spectrum—likely abandoned post-RLBY losses. No revival path; any Doki cash infusion would trigger SEC scrutiny. Ties to the mess amplify delisting risks.
How They Fit the Bigger PictureThe Pattern: Doki's MO—reverse merge into shells (RLBY 2019, FTRS/OBCN 2020-2021), load with Vivos-style staffing deals, default on debts, face fraud suits. RLBY's receivership (ruling expected Dec 2025-Jan 2026) could cascade: Seized shares (1-2M RLBY) might force Doki to dump FTRS holdings for cash, worsening dilution there.
No Direct Overlap: Unlike Vivos' $7.7M RLBY judgment, FTRS/OBCN aren't in court docs—but forums tie them as "Doki trash" vehicles.
investorshub.advfn.com
Probability of spillover litigation: Medium (40%), if clawbacks expand.
Investment Implications: Avoid both—FTRS has faint upside if Doki exits (post-RLBY resolution, Q2 2026 base-case); OBCN is a zero. RLBY holders: Watch for 8-Ks on asset traces. This mess underscores OTC risks: Doki's network has torched ~$10M+ in shareholder value across tickers.
AI
